Original papers in peer reviewed journals
1. Galun E, Epstein Y. Serum creatine kinase activity following a 120km march. Clin Chem Acta.143:281-283, 1984.
2. Galun E, Ben-Chetrit, E. Possible prevention of tick-born relapsing fever in patients infected with borrelia recurrentis. J Inf Dis. 150:617, 1984.
3. Galun E, Braverman D, Ligumsky M. Primary mesothelioma of the peritoneum. Harefuah (In Hebrew)153:593-594, 1985.
4. Slavin S, Waldman H, Or R, Cividalli G., Naparstek E, Steiner-Salz D. Michaeli J, Galun E, Weiss L, Samuel S, Rachmilewitz EA, Reisner Y. Prevention of graft versus host disease in allogenic bone marrow transplantation for leukemia by T cell depletion in vitro prior to transplantation. Transplant Proc. 17:465-467, 1985.
5. Shalit M, Flugelman YM, Harats N, Galun E, Ackerman Z, Kopolovic J, Eliakim M. Quinindine induced vasculitis. Arch Intern Med. 145:2051-2052, 1985.
6. Slavin S, Or R, Weiss L, Cividalli G, Steiner-Salz D, Galun E, Samuel S, Galili N, Olschwang D, Hale G, Waldmann H. Monoclonal antibodies in hematopathology IN: Grignano F, Martell MF, Mason DY, Eds., Serono Symposia Publications. New York: Raven Press, pp. 163-167, 1985.
7. Slavin S, Or R, Weiss L, Steiner-Salzz D, Cividalli G, Brautbar C, Weshler Z, Galun E, Samuels S, Galili D, Ephros M, Shapiro M, Hale G, Waldmann H. Elimination of graft versus host disease in matched allogenic leukemia transplant recipients using CAMPATH-1. IN: Klauss GGB, Ed., Microenvironments in the Lymphoid System. New York: Plenum Press, pp. 813-818, 1985.
8. Galun E, Ben-Yehuda A, Ben-Chetrit E, Burlatsky Y, Gross D. Insulinoma complicating pregnancy. Case report and
review of the literature. Am J Obst Gynecol. 155:64-65, 1986.
9. Galun E, Flugelman MY, Rachmilewitz D. Pyoderma gangrenosum complicating ulcerative colitis; successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol. 81(10):988-989, 1986.
10. Libson E, Bloom RA, Galun E, Polliack A. Granulocytic sarcoma (chloroma) of bone:The CT appearance. Computerized Radiol. 10:175-176, 1986.
11. Galun E, Burstein R, Assia E, Tur-Kaspa I, Epstein Y. Changes of white blood cell count during prolonged exercise. I nt J of Sport Med. 8:253-255,1986 (Also published in the Yearbook of Sports Medicine, 1988).
12. Stendig-Lindberg G, Epstein Y, Galun E, Shapira Y, Schonberger E, Wacker WEC. Changes in serum magnesium concentration after strenuous exercise. J Am Coll Nutr. 6:35-40, 1987.
13. Galun E, Oren R, Glikson M, Friedlander M, Heyman A. Hemolytic anemia induced by phenazopyridine in G-6-PD deficiency. Drug Intell and Clin Pharm (Letter). 21:921-922, 1987.
14. Galun E, Tur-Kaspa I, Assia E, Epstein Y, Burstein R. Prediction of physical performance through muscle enzymes activity. Eur J App Physiol. 57:597-600, 1988.
15. Mosseri M, Rosenheck S, Galun E, Milgarter E, Gottsman M. Thrombolysis of a stuck and thrombosed prosthetic tricuspid valve with a single dose of streptokinase. Isr J Med Sci. 24:114-116, 1988.
16. Libson E, Fields, S Strauss S, Okon E, Galun E, Polliack A. Widespread Castleman's Disease; CT and ultrasound findings. Radiol. 166:753-755, 1988.
17. Shouval D, Anton M, Galun E, Sherwood JB. Erthropoietin induced polycythemia in athymic mice following transplantation of human renal carcinoma cell line. Cancer Res. 48:3430-3434, 1988.
18. Feigin RD, Glikson M, Ben-Baruch N, Galun E, Gur H. Induction of ovulation causing bloody ascites in a woman with endometriosis. Am J Obs and Gyn. 159:1161-1162, 1989.
19. Glikson M, Galun E, Schlesinger M, Cohen D, Haskell L, Rubinow A, Eliakim M. Polyarteritis nodosa and familial Mediterranean fever: Report of two cases and review of the literature. J Rheumatol. 16:536-539, 1989.
20. Galun E, Rubinow A. Photocopeir's papillitis. Lancet (letter) 2:929, 1989.
21. Lapidot T, Galun E. Chorea induced by hyperglycemia. Arch Intern Med.(letter), 149:1905, 1989.
22. Glikson M, Pollack A, Feigin R, Galun E, Rubinow A. Nifedipin and prazosin in the management of pulmonary hypertension in CREST syndrome. Chest 98: 759-761, 1990.
23. Burstein R, Galun E. Exercise-induced hyponatremia-as rare as believed? Medicine and Science in Sports and Exercise (letter) 22:879, 1990.
24. Galun E, Shouval D, Adler R, Shachar M, Wilchek M, Hurwitz E, Sela M. The effect of anti-alpha-fetoprotein- adriamycin conjugates on a human hepatoma. Hepatology 11:578-584, 1990.
25. Flugelman YM, Galun E, Ben-Chetrit E, Caraco J, Rubinow A. Brucellosis in patients with heart disease: When should endocarditis be diagnosed? Cardiology 77:313-317, 1990.
26. Glikson M, Dresner-Feigin R, Pollack A, Wolf D, Galun E, Tur Kaspa R. Pentamidine induced cardiotoxicity. Isr J Med Sci. 26:588-589, 1990.
27. Burstein M, Galun E, Ben-Chetnit E. Idiopathic sclerosing peritonitis in man. J. Clin.Gastroenterol. 12:698-701, 1990.
28. Galun E, Flugelman YM, Glikson M, Eliakim M. Failure of long term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation.Chest 99:1038-1040, 1991.
29. Blum HE, Galun E, T. Jake Liang, v. Weizsaecker F, Wands JR. A naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J. Virol. 65: 1836-1842, 1991.
30. Blum HE, Galun E, v. Weizsaecker F, Wands JR. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet (letter) 1:1230, 1991.
31. IIan Y, Hillman M, Oren R, Galun E, Shalit M. Undetectable ceruloplasmin levels in an autoimmune chronic active hepatitis patient. Gut 32:549-550, 1991.
32. Blum HE, T. Jake Liang, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 14:56-62, 1991.
33. Bloom A, Rubinow A, Galun E. Predominance of renal involvement in male patients with systemic lupus erythematosus. Clinical and Experimental Rheumatology 9:206-7, 1991.
34. Blum HE, Galun E, T. Jake Liang, Hasegawa K, Wands JR. Structure and biological characteristics of a naturally occurring pre-core/core mutant of hepatitis B virus. In: Hollinger BL (ed). Proceeding of the 1990 Int'l Symposium on Viral Hepatitis and Liver Disease 861-865, 1991.
35. T. Jake Liang, Blum HE, Hasegawa K, Takahashi H, Galun E, Wands JR. Detection and transmission of low level hepatitis B related virus. In: Hollinger BC (ed). Proceeding of the 1990 Int'l Symposium on Viral Hepatitis and Liver Disease 684-687, 1991.
36. Glikson M, Gil-Ad I, Galun E, Dresner R, Zilberman S, Halperin Y, Okon E, Laron Z, Rubinow A. Acromegaly due to ectopic growth hormone releasing hormone secretion by a bronchial carcinoid tumor. Acta Endocrinologica 125:366- 371, 1991.
37. Flugelman MY, Weisstub E, Galun E, Weiss AT, Fischer D, Kaplan De-Nor A, Gotsman MS, Eliakim M. Clinical, psychological and thallium stress studies in patients with chest pain and normal coronary arteries. International J. of Cardiology 33:401–408, 1991.
38. Galun E, Tur-Kaspa I, Assia E, Burstein R, Strauss N, Epstein Y, Popovitzer MM. Hyponatremia induced by exercise: a 24 hour endurance march study. Mineral & Electrolyte Metabolism 17:315-320, 1991.
39. Ozturk M, Bressac B, Puisieux A, Kew M, Volkman M, Bozecali S, Bella Mura J, de la Monte S, Carlson R, Blum HE, Wands JR, Takahashi H, Weizacker Fv, Galun E, Kar S, Carr B, Schroder C, Erken E, Varilini S, Rustgi V, Prat J, Toda G, Koch H, Liang X, Tang Z, Shouval D, Lee H, Vyas G, Sarosi I. p53 hotspot mutation in hepatocellular carcinoma is linked to aflatoxin exposure. Lancet 338:1356–1359, 1991.
40. Blum HE, Zhang ZS, Galun E, F v Weizsacker, TJ Liang, JR Wands. Hepatitis B virus x-protein is not central to the viral life cycle in vitro. J Virol 66:1223-1227, 1992.
41. Galun E, Offensperger W-B, v Weizsäcker F, Offensperger S, Wands JR, Blum HE. Human non-hepatocytes support hepadnaviral replication and virion production. J General Virology 73:173-178, 1992.
42. Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A: Review of 14 cases and literature survey. Medicine (Baltimore) 71:14-23, 1992.
43. Ilan Y, Galun E. Acute hepatitis A complicated by acute glomerulonephritis. J Clin Gastroenterol 15:85,1992.
44. Liang T-J, Rustgi V, Galun E, Blum H. HCV RNA in patients with chronic hepatitis C treated with interferon-alpha. J Med Virol 40:69–75,1993.
45. Burnstein R, Hourvitz A, Epstein Y, Dvir Z, Moran D, Altar J, Shemer J, Shalev A, Galun E. The relationship between short-term antibiotic treatments and fatigue in healthy individuals. Eur J Appl Physiol 66:372-375, 1993.
46. Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J, Ozturk M. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J 7:1407-1413, 1993.
47. Schwartz E, Galun E. Hepatitis A virus infection enhances acute hepatitis E virus infection. Medical Hypothesis 42: 198-202, 1994.
48. Ben-Sasson SA, Finstone A, Moskovitz M, Maron R, Weinner M, Leichter I, Margulis J, Stein P, Popovtzer M, Rubinger D, Rouash T, Harrari H, Galun E. Extended duration of vertical position cases impaired bone-metabolism. Eu J Clin Invest 24: 421-425,1994.
49. Schwartz E, Ilan Y, Galun E. Hepatitis E virus infection. Harefuah, 127: 249-51, 1994. (in Hebrew).
50. Galun E, Ilan I, Livni N, Ketzinel M, Pizov G, Nagler A, Eid A, Rivkind A, Laster M, Ron N, Blum HE, Shouval D. Hepatitis B virus infection associated with hematopoietic tumors. Am J Path, 145: 1001-7, 1994.
51. Ilan Y, Shouval D, Galun E, Feder R, Adler R, Yatzive S. Correction of b-glucuronidase,. deficiency in mice by intrasplenic transplantation of isolated hepatocytes. International Communication in Hepatology, 3: 97-104,1995.
52. Galun E, Burakova T, Lubin I, Shezen E, Kahana Y, Eid A, Ilan Y, Rivkind A, Ketzinel M, Pisov G, Shouval D, Reisner Y. Hepatitis C viremia in SCID>BNX chimeric mice. J Inf Dis 172:25-30, 1995.
53. Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, Shouval D, Galun E. Expression of P53 in patients with cirrhosis with or without hepatocellular carcinoma. Cancer, 75: 2420-2426, 1995.
54. Marcus H, David M, Canaan A, Kulova L, Lubin I, Segall H, Dennis L, Erlich P, Galun E, Gan J, Laster M, Reisner Y. Memory and primary human humoral responses in human/mouse radiation chimera. Blood, 86:398-406, 1995.
55. Abramov Y, Galun E, Granat M, Barak V, Plotkin V, Samueloff A. Postpartum systemic capillary leak syndrome: A possible etiology. Acta Obstet Gynecol Scand, 74: 395-398, 1995. (case report)
56. V Weizsäcker F, Maeda E, Brown N, Poynard T, Galun E, Labeit S, Caput J-C, Arima T, Blum HE, Wands JR. Hepatitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusion. International Communication in Hepatology, 4:80-87, 1995.
57. Zelnger J, Putterman, Ilan Y, Dann EJ, Zveibil F, Shvil Y, Galun E. Hyponatremia associated with moderate exercis. Am J Med Sci, 311:86-91, 1996.
58. Ilan Y, Galun E, Nagler A, Baruch Y, Livni N, Tur-Kaspa R. Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation. Liver Transplantation and Surgery, 2:206-210, 1996.
59. Ilan Y, Shouval D, Galun E, Goldin E, Ligumsky M, Friedman R, Tur-Kaspa R. Esophageal malignancy after liver transplantation in a patient with Barret’s esophagus. Scan J Gastroenterology,31:415-416, 1996. (case report)
60. Rojansky N, Shushan A, Livni N, Jurim O, Sulam M, Galun E. Pregnancy associated with colon carcinoma overexpressing P53. Gynecologic Oncology, 64: 516-520, 1997. (case reports).
61. Klain A, Barsuk R, Dagan S, Nussbaum O, D Shouval, Galun E. Nucleic acid extraction method from hemolytic serum for PCR amplification of hepatitis B virus (HBV) DNA sequences. J Clin Microb 35:1897-1899, 1997.
62. Ilan Y, Gabay E, Amit G, Feder R, Galun E, Adler R, Shouval D. Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen. J Hepatology 27:170-175, 1997.
63. Safadi R, Shouval D, Ashur Y, Eid A, Jurim O, Livni N, Galun E. Natural history of HCV viremia following liver transplantation and clinical course of re-infection. Transplantation Proc. 29:2629-2633, 1997.
64. Eran R, Lubin I, Terkieltaub D, Ben-Moshe O, Uhlmann R, Tzahor T, Moss S, Ilan E, Zauberman A, Shouval D, Galun E, Daudi N, Marcus H, Reisner Y, Dagan S. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology, 93: 154-61, 1998.
65. Eid A, Zamir G, Ilan Y, Galun E, Safadi R, Schaaps T, Berlatzky Y, Shouval D, Jurim O. Liver transplantation across ABO barrier: the role of plasmapheresis. Transplantation proceedings, 30:701-3, 1998.
66. Eid A, Simcha E, Galun E, Shafrir E., Ziv E, Bar-on H. Effect of donor feeding and fructose reperfusion on warm ischemia injury of rat livers. Transplantation proceedings, 30:767-8, 1998.
67. Safadi R, Ilan Y, Eid A, Galun E, Ashur Y, Goldin E, Papo O, Blachar A, Jurim O. Solid tumors after liver transplantation. Transplantation Proceedings, 31:1894-5, 1999.
68. Safadi R, Ilan Y, Galun E, Ashur Y, Goldin E, Papo O, Jurim O, Blacher A, Eid A. Primary sclerosing cholangitis and liver transplantation. Transplantation Proceedings, 31:1896, 1999.
69. Safadi R, Ilan Y, Jurim O, Schenker J, Galun E, Ashur Y, Eid A. Pregnancy and liver transplantation. Transplantation Proceedings, 31:1899-900, 1999.
70. Ilan E, Burakova T, Dagan S, Nussbaum O, Lubon I, Eren R, Ben-Moshe O, Arazi J, Berr S, Neville L, Yuen L, Mansour TS, Gillard J, Eid A, Jurim O, Shouval D, Reisner Y, Galun E. The HBV - Trimera mouse: A model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology, 29:553-62, 1999.
71. Bocher WO, Marcus H, Shakarchy R, Dekel B, Galun E, Reisner Y. Frequency analysis of antigen specific B and T cells in human/mouse radiation chimera following immunization with a primary or recall antigen. Immunology 96:634- 41, 1999.
72. Schwartz E, Jenks NP, Van Damme P, Galun E. Hepatitis E virus infection among travelers. Clinical Infectious Diseases 29:1312-4, 1999.
73. Haviv YS, Galun E, Sharkia M, Safadi R. Pancreatitis following hepatitis A vaccination. Eur J Med Res 5:229-230, 2000.
74. Ketzinel-Gilaad M, Colodner SL, Hadary R, Granot E, Shouval D, Galun E. (2000). Transient transmission of hepatitis C virus from mother to newborns. Eu J Clin Mic 19:267-74.
75. Bocher WO, Galun E, Marcus H, Daudi N, Terkieltaub D, Shouval D, Lohr HF, Reisner Y. (2000). Failure of chronic hepatitis B virus carriers to produce surface antigen specific antibodies in human/mouse radiation chimera due to an antigen specific TH1 helper cell defect. Hepatology 31:480-7.
76. Galun E, Nahor O, Eid A, Jurim O, Rose-John S, Blum HE, Nussbaum O, Ilan E, Daudi N, Shouval D, Reisner Y, Dagan S. (2000). Human IL-6 facilitates hepatitis B virus infection in vitro and in vivo. Virology, 270:299-309.
77. Lavon I, Goldberg I, Amit S, Jung S, Tsuberi BZ, Barshak I, Kopolovic J, Galun E, Bujard H, Ben-Neriah Y. (2000). High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nature Medicine, 6:573-7.
78. Israeli E, Eid A, Ilan Y, Adler R, Galun E, Ashur Y, Jurim O, Safadi R. (2000). The course of hepatitis B virus infection after liver transplantation. Transplantation Proc., 32:711.
79. Galun E, Zeira E, Pappo O, Peters M, Rose – John S. (2000). Liver regeneration induced by a designer human IL- 6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J, 14: 1979-1987.
80. Safadi R, Ergunay K, Ilan Y, Klein A, Shouval D, Manny N, Harush N, Galun E. (2000). TT-virus infection in Israeli patients with fulminant hepatic failure. Vox Sanguinis, 79:242-245.
81. Eran R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, Ben-Moshe O, Kitchinzky A, Berr S, Gopher J, Zauberman A, Galun E, Shouval D, Daudi N, Eid A, Jurim O, Magnius LO, Hammas B, Reisner Y, Dagan S. (2000). Preclinical evaluation of two human anti-HBV monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology, 32:588-96.
82. Safadi R, Ketzinel-Gilaad M, Or R, Ilan Y, Nagler A, Naparstek E, Shouval D, Galun E. (2001). Aplastic anemia associated hepatitis, treated by bone marrow transplantation. Bone Marrow Transplantation 27:183-190.
83. Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JA. (2001). Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Molecular Therapy 3: 683-687.
84. Honigman A, Zeira E, Patricia O, Abramovitch R, Tavor E, Bar I, Zilberman Y, Rabinovsky R, Gazit D, Joseph A, Panet A, Shai E, Palmon A, Laster M, Galun E. (2001). Imaging of transgene expression in live mice. Molecular Therapy 4:239-249.
85. Sermoneta-Gertel S, Donchin M, Adler R, Baras M, Shouval D, Manny N, Galun E. (2001). Hepatitis C virus infection in hospital employees. Infection Control and Hospital Epidemiology, 22:754-761.
86. Goldenberg D, Ayesh S, Schneider T, Pappo O, Jurim O, Eid A, Fellig Y, Dadon T, Ariel I, de Groot N, Hochberg A, Galun E.(2002). Analysis of Differentially Expressed Genes in Hepatocellular Carcinoma Using cDNA Arrays. Molecular Carcinogenesis 33:113-24.
87. Ilan E, Arazi J, Nussbaum O, Zauberman A, Eren R, Lubin I, Ben-Moshe O, Kischitzky A, Litchi A, Margalit I, Gopher J, Mounir S, Cai W, Daudi N, Eid A, Jurim O, Czerniak A, Galun E, Dagan S. (2002). The hepatitis C virus - Trimera mouse: A model for evaluation of anti-HCV therapeutic agents. J Infectious Disease 185:153-61.
88. Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot I, Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S. (2002). Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology 35:673-679, 2002.
89. Bar I, Zilberman Y, Zeira E, Galun E, Honigman A, Turgeman G, Clemens T, Gazit Z, Gazit D. (2003). Molecular imaging of the skeleton: Quantitative real time bioluminescence monitoring gene expression in repair and development. J Bone & Mineral Research, 18:570-8.
90. Gropp M, Itsykson P, Singer O, Ben-Hur T, Reinhartz E, Galun E, Reubinoff BE. (2003). Stable genetic modification of human embryonic stem cells by lentiviral vectors. Molecular Therapy, 7:281-7.
91. Mitchell LA, Galun E. (2003). Rectal immunization of mice with hepatitis A vaccine induces a strong systemic and local immune responses that are superior to those elicited by parenteral immunization. Vaccine 21: 1527 -38.
92. Beider K, Nagler A, Wald O, Franitza S, Dagan-Berger M, Wald H, Giladi H, Brocke S, Hanna J, Mendelbaum O, Darash-Yahana M, Galun E, Peled A. (2003). Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood, 102:1951-8.
93. Zeira E, Manevitch A, Khatchatouriants A, Pappo O, Hyam E, Tavor E, Honigman A, Lewis A, Galun E. (2003). Femtosecond infrared laser - an efficient and safe in vivo gene delivery system for prolonged expression. Molecular Therapy, 8:342-50.
94. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. (2003). Small Interfering RNA Inhibits HBV Replication in Mice. Molecular Therapy, 8:769-76.
95. Arad U, Axelrod J, Ben-nun-Shaul O, Oppenheim A, Galun E. (2004). HBV enhances transduction of human hepatocytes by SV40-based vectors. J Hepatology 40:520-6.
96. Abramovich R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O, Rechavi G, Galun E, Honigman A. (2004). The pivotal role of CREB in tumor progression. Cancer Res, 64:1338-46.
97. Gafni Y, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, Galun E, Gazit Z, Jorgensen C, Gazit D. (2004). Gene Therapy Platform for Bone Regeneration using Exogenously Regulated, AAV2 based, Gene Expression System. Molecular Therapy 9:587-95.
98. Wald O, Pappo O, Safadi R, Dagan-Berger M, Beider K, Wald H, Franitza S, Weiss I, Avniel S, Hanna J, Zamir G, Eid A, Mandelboim O, Spengler U, Galun E, Peled A. (2004). Involvement of CXCL12/CXCR4 Pathway in Advanced Hepatitis C Virus Associated Liver Disease. Eu J Immunology 34:1164-74.
99. Franitza S, Grabovsky V, Wald O, Weis I, Beider K, Dagan M, Darash-Yahana M, Nagler A, Brocke S, Galun E, Alon R, Peled A.(2004). Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NK T and CD56+CD16+ NK cells regulates their interaction with endothelial cells. Eur J Immunology 34:1333-41.
100. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Kasem S, Galun E, Peled A. (2004). High levels of CXCR4 expression in human prostate cancer stimulates tumor growth and metastasis. FASEB J 18:1240-2. 6.820;
101. Matouk I, Ayesh B, Schneider T, Ayesh S, Ohana P, de-Groot N, Hochberg A, Galun E. (2004). Oncofetal splice- pattern of the human H19 Gene. BBRC 318: 916-9.
102. Condiotti R, Curran MA, Nolan GP, Gross E, Galun E. (2004). Feline immunodeficiency virus-based lentiviral vectors for liver-directed gene expression. BBRC 320:998-1006.
103. Felig Y, Almogy G, Galun E, Ketzinel-Gilad M. (2004). A hepatocellular carcinoma cell line producing mature hepatitis B viral particles. BBRC 321:269-74.
104. Rivo J, Zeira E, Galun E, Matot I. (2004). Activation of A3 Adenosine Receptors Attenuates Lung Injury Following In- Vivo Reperfusion. Anesthesiology 101:1153-1159.
105. Rivo J, Zeira E, Galun E, Matot I. (2004). Activation of A3 adenosine receptor provides lung protection against i ischemia-reperfusion injury associated with reduction in apoptosis. Am J Transplantation 4:1941-1948.
106. Wald O, Pappo O, Ben Ari Z, Azzaria E, Wiess I, Gafnovitch I, Wald H, Spengler U, Galun E, Peled A. (2004). CCR532 allele is associated with reduced liver inflammation in HCV infection. Eur. J. Immungenetics 31:249-252.
107. Pikarsky E, Porat RM, Stein I, Abramovich R, Amit S, Kasem S, Gutkovich-Pyest E, Galun E, Ben-Neriah Y. (2004). NF-kB functions as a tumor promoter in a mouse model of inflammation-associated liver cancer. Nature 43:461-6.
108. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness.
Blood 105:2214-9.
109. Arad U, Zeira E, Abd El-Latif M, Pappo O, Mitchell L, Galun E, Oppenheim A. (2005). Liver directed gene therapy by SV40 based vectors using the hydrodynamic injection. Human Gene Therapy 16:361-71.
110. Lippin Y, Dranitzki-Elhalel M, Brill-Almon E, Mei – Zahav C, Mizrachi S, Liberman Y, Iaina A, Kaplan E, Podjarny E, Shani N, Galun E. (2005). Human erythropoietin gene therapy for patients with chronic renal failure. Blood 106:2280- 2286.
111. Shai E, Palmon A, Panet A, Marmary Y, Curran MA, Nolan GP, Galun E, Condiotti R. (2005). Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction. Molecular Therapy 12:
137-143.
112. Freeman AI, Zakay-Rones Z, Gomori JM, Linetsky E, Panet A, Libson E, Linda R, Greenbaum G, Irving CS, Galun E, Siegal T. (2006). PhaseI/II trail of intravenous NDV-HUJ (OV001) oncolytic virus in recurrent glioblastoma multiforme. Molecular Therapy 13:221-228.
113. Shani A, Zaretski A, Alex M, Sagie A, Ben Basst H, Darash Yahana M, Weiss ID, Pal B, Wald O, Ad-El D, Fujii N, Arenzana-Seisdedos F, Jung S, Galun E, Gur E, Peled E. (2006). Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Investigative Dermatology 126:468-476.
114. Wald O, Weiss ID, Wald H, Weiss L, Bar-Shavit Y, Beyder K, Flaishon L, Nagler A, Galun E, Murphy PM, Shachar I, Farber J, Peled A. (2006).NK mobilization from bone marrow and spleen is regulated by IFN-and IL-18. J
Immunology 176:4716-4729.
115. Dagan-Berger M, Feniger-Barish R, Galun E, Ben-Baruch A, Peled A. (2006). Serine 245 in the third intracellular loop of CXCR3 regulates receptor desensitization, but not internalization. Blood 107:3821-31.
116. Eren R, Landstein D, Terkieltaub D, Nussbaum O, Zauberman A, Ben-Porath J, Gopher J, Buchnick R, Kovjazin R, Rosenthal-Galili Z, Aviel S, Ilan E, Shoshany Y, Neville L, Waisman T, Ben-Moshe O, Kischitsky A, Foung SKH, Keck Z-Y, Pappo O, Eid A, Jurim O, Zamir G, Galun E, Dagan S. (2006). Preclinical evaluation of two neutralizing human monoclonal antibodies against HCV: A potential treatment to prevent re-infection in liver transplant patients. J Virology 80:2654-2664.
117. Katzenellenbogen M, Pappo O, Barash H, Klopstock N, Mizrahi L, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Mitchell LA, Kohen R, Domany E, Galun E, Goldenberg D. (2006). Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice. Cancer Res 66:4001-4010.
118. Ketzinel-Gilad M, Zauberman A, Nussbaum O, Shoshany Y, Ben-Moshe O, Pappo O, Felig Y, Ilan E, Wald H, Dagan S, Galun E. (2006). A simplified HBV animal model to study HBV biology and antiviral therapy. Hepatology Research 34:228-237.
119. Ben-Dor I, Itsykson P, Goldenberg D, Galun E, Reubinoff BE. (2006). Lentiviral vectors harboring a dual gene system allow high and homogenous transgene expression in selected polyclonal human embryonic stem cells. Molecular Therapy 14:255-267.
120. Mitchell LA, Joseph A, Kedar E, Barenholz Y, Galun E. (2006). Mucosal immunization with hepatitis A virus: Antibody response are enhanced by co-administration of synthetic oligodeoxynucleotides and cationic lipids. Vaccine 24:
5300-5310.
121. Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Tur-Kaspa R, Eren R, Dagan S, Graham N, Williams PV, Andrews J. (2006). Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transplantation 12: 1381-1389.
122. Wald O, Izhar U, Amir G, Avniel S, Bar-Shavit Y, Wald H, Weiss I, Galun E, Peled A. (2006). CD4+, CXCR4high, CD69+ T cells accumulate in lung carcinoma. J Immunology 177:6983-90.
123. Galun E, Terrault N, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, Zohar M, Buchnik R, Ackerman Z, Safadi R, Ashur Y, Misrachi S, Liberman Y, Rivkin L, Dagan S. (2007). Clinical Evaluation (Phase I) of a Human Monoclonal Antibody against Hepatitis C Virus: Safety and Antiviral Activity. J Hepatology 46:37-44.
124. Matot I, Weiniger CF, Zeira E, Galun E, Joshi BV, Jacobson KA. (2006). A3 adenosine receptors and mitogen- activated protein kinases in lung injury following in vivo reperfusion. Critical Care 10:R65- web publication of Bio-Med Central.
125. Rivo J, Zeira E, Galun E, Einav S, Linden J, Matot I. (2007) Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock 27:266-273.
126. Katzenellenbogen M, Mizrahi L, Pappo O, Olam D, Barash H, Domany E, Galun E, Goldenberg D. (2007). Molecular mechanisms underlying the effect of chemopreventive agents on primary liver tumor development in a mouse model. Molecular Cancer Therapeutics. 6:1283-91.
127. Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E, Giladi H. (2007) TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. Journal of Cellular Biochemistry 100:1301-12.
128. Zamir G, Zeira E, Gelman AE, Shaked A, Olthoff KM, Eid A, Galun E. (2007). Replication-deficient adenovirus induces host topoisomerase I activity: implications for adenovirus-mediated therapeutic gene expression. Molecular Therapy 15:772-81.
129. Ben Moshe T, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E, Schuchmann M, Abramovitch R, Galun E, Wallach D. (2007). Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology. 45:1014-24.
130. Harel H, Gross E, Matot I, Spira G, Vlodavsky I, Galun E, Abramovitch R. (2007). MRI as a novel tool for monitoring perfusion and hemodynamic changes in the rat liver. Radiology. 243:727-35.
131. Zeira E, Manevitch A, Manevitch Z, Kedar E, Gropp M, Daudi N, Barsuk R, Harati M, Yotvat H, Troilo P, Griffiths T, Pacchione S, Roden D, Niu Z, Nussbaum O, Zamir G, Pappo O, Hemo I, Lewis A, Galun E. (2007). Femtosecond laser - A new intradermal DNA delivery method for efficient, long-term gene expression and genetic immunization. FASEB J. 21:3522-33.
132. Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D. (2007). Molecular mechanisms of liver carcinogenesis in the Mdr2-knockout mice. Molecular Cancer Research 5:1159-70.
133. Abraham M, Beyder K, Begin M, Wald H, Weiss ID, Nagler A, Galun E, Peled A. (2007). Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. Stem Cells 25:2158-2166.
134. Klopstock N, Levy C, Olam D, Galun E, Goldenberg D. (2007).Testing transgenic regulatory elements through live mouse imaging. FEBS Letters 58:3986-90.
135. Matouk IJ, DeGroot N, Ayesh S, Abu-lail R, Hochberg A, Galun E. (2007).The H19 non coding RNA – is essential for human tumor growth. PLoS One 2:e845.
136. Ben Moshe T, Kang T-B, Kovalenko A, Barash H, Abramovitch R, Galun E, Wallach D. (2008). Cell-autonomous and non-cell-autonomous functions of caspase-8. Cytokine & Growth Factor Reviews. 19: 209–217.
137. Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, Galun E, Axelrod JH. (2008). IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury. JASN 19:1106-15.
138. Barash H, Gross E, Edrei Y, Spira G, Vlodavsky I, Galun E, Matot I, Abramovitch R. (2008). Functional MRI Monitoring of Pathological Changes in the Rat Liver Utilizing Hyperoxia and Hypercapnia. Hepatology 48:1232-41.
139. Tzur G, Levy A, Meiri E, Barad O, Spector Y, Bentwich Z, Mizrahi L, Katzenellenbogen M, Ben-Shushan E, Reubinoff BE, Galun E. (2008) microRNA Expression Patterns and Function in Endodermal Differentiation of Human Embryonic Stem Cells. PLoS One 3:e3726.
140. Beider K, Abraham M, Begin M, Wald H, Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E, Nagler A, Peled E. (2009). Interaction Between CXCR4 and CCL20 Pathways Regulate Tumor Growth. PLoS One 4:e5125.
141. Ram SE, Galun E. (2009). AAV2-GDNF Gene Therapy for Parkinson's Disease. Hum Gene Ther. 20:430-1.
142. Zorde-Khvalevsky E, Abramovitch R, Harel-Barash H, Rivkin L, Spivak-Pohis I, Rachmilewitz J, Galun E, Giladi H. (2009). TLR3 signaling attenuates liver regeneration. Hepatology 50:198-206.
143. Noam Rudich N, Zamir G, Pappo O, Shlomai Z, Faroja M, Weiss ID, Wald H, Galun E, Peled A, Wald O. (2009). Focal liver necrosis appears early after partial hepatectomy and is dependent on T-cells and antigen delivery from the gut. Liver International 29:1273-84.
144. Israel A, Sharan R, Ruppin E, Galun E. (2009). Increased MicroRNA Activity in Human Cancers. PLoS One 4:e6045.
145. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. (2009). Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol. 21:688-92.
146. Tzur G, Israel A, Levy A, Benjamin H, Meiri E, Shufaro Y, Meir K, Khvalevsky E, Spector Y, Rojansky N, Bentwich Z, Reubinoff BE, Galun E. (2009). Comprehensive Gene and microRNA Expression Profiling Reveals a Role for microRNAs in Human Liver Development. PLoS One 4:e7511.
147. Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E. (2009). A plant-derived recombinant human Glucocerebrosidase enzyme - A preclinical and Phase I investigation. PLoS One 4: e4792.
148. Klopstock N, Katzenellenbogen M, Pappo O, Sklair-Levy M, Olam D, Mizrahi L, Potikha T, Galun E, Goldenberg D. (2009). HCV tumor promoting effect is dependent on host genetic background. PLoS One 4(4):e5025.
149. Weiss ID, Wald O, Wald H, Beyder K, Avrahm M, Galun E, Nagler A, Peled A. (2010). IFN--induced natural killer cell proliferation protects mice from influenza virus lethal effect. J of Infection and Cytokine Research 30:439-49.
150. Barasa H, Gross E, Edrei Y, Israel A, Cohen I, Ben-Moshe T, Pappo O, Pikarsky E, Goldenberg D, Shiloh Y, Galun E, Abramovitch R. (2010). The accelerated carcinogenesis following liver regeneration is associated with chronic inflammation induced double strand DNA breaks. Proc Natl Acad Sci (USA) 107:2207-12.
151. Grinshpun A, Condiotti R, Waddington S, Peer M, Zeig E, Peretz S, Simerzin A, Chou J, PhD; Pann C-J, Giladi H, Galun E. (2010). Neonatal Gene Therapy of Glycogen Storage Disease Type Ia Using A Feline Immunodeficiency Virus Based Vector. Molecular Therapy 18:1592-8.
152. Matouk IJ, Mezan S, Mizrahi A, Ohana P, deGroot N, Galun E, Hochberg A. (2010). The Oncofetal H19 RNA connection: Hypoxia, p53 and cancer. BBA - Molecular Cell Research 1803:443-51.
153. Cohen-Haguenauer O, Creff N, Cruz P, Tunc C, Aïuti A, Baum C, Bosch F, Blomberg P, Cichutek K, Collins M, Danos O, Dehaut F, Federspiel M, Galun E, Garritsen H, Hauser H, Hildebrandt M, Klatzmann D, Merten O, Montini E, O’Brien T, Panet A, Rasooly L, Scherman D, Schmidt M, Schweitzer M, Tiberghien P, Vandendriessche T, Ziehr H, Ylä-Herttuala S, von Kalle C, Gahrton G, M Carrondo. (2010). Relevance of an Academic GMP Pan-European Vector Infra-structure (PEVI). Current Gene Therapy 10:414-22.
154. Nechemia-Arbely Y, Shriki A, Denz U, Drucker C, Scheller J, Raub J, Pappo O, Rose-John S, Galun E, Axelrod JH. (2011). Early Hepatocyte DNA Synthetic Response Posthepatectomy is Modulated by IL-6 Trans-Signaling and PI3K/AKT Activation . J Hepatology 54:922-9.
155. Peled A, Beider K, Begin M, Abraham M, Wald H, Weiss ID, Wald O, Pikarsky E, Zeira E, Eizenberg O, Galun E, Hardan I, Engelhard D, Nagler A. (2011). The CXCR4 Antagonist 4F-benzoyl-TN14003 Inhibit Leukemia and Multiple Myeloma Tumor Growth. Exp Hematology 39:282-92.
156. Weiss ID, Shoham1 H, Wald O, Wald H, Beider K, Abraham M, Galun E, Nagler A, Peled A. (2011). CCR5 regulates the proliferation and trafficking of natural killer cells under physiological conditions. Cytokine 54:249-57.
157. Edrei Y, Gross E, Corchia N, Tsarfaty G, Galun E, Pappo O, Abramovitch R. (2011). Vascular Profile Characterization of Liver Tumors by MRI using Hemodynamic Response Imaging in Mice. Neoplasia 13:244-53.
158. Globerman AS, Chaouat M, Shlomai Z, Galun E, Zeira E, Zamir G. (2011). Efficient transgene expression from naked DNA delivered into an arterio-venous fistula model for kidney dialysis. J of Gene Medicine. 13:611-21.
159. Sonnenblick A, Shriki A, Galun E, Axelrod JH, Daum H, Rottenberg Y, Hamburger T, Mali B, Peretz T. (2012). Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis. Clin Transl Oncol. 14:232-6.
160. Manevitch Z, Lewis A, Levy C, Zeira E, Banin E, Manevitch A, Khatchtourints A, Pe’er J, Galun E, Hemo I. (2012). Subsurface Femtosecond Tissue Alteration: Selectively Photobleaching Macular Degeneration Pigments in Near Retinal Contact. The Journal of Physical Chemistry. 116:6945-51.
161. Hen G, Yosefi S, Mygdal S, Condiotti R, Galun E, Bor A, Sela-Donenfeld, Friedman-Einat M. (2012). Gene Transfer to Chicks Using Lentiviral Vectors Administered via the Embryonic Chorioallantoic Membrane. PlosOne. 7:e36531.
162. Klein M, Lotem MM, Peretz TY, Zwas ST, Mizrachi S, Liberman Y, Chisin RY, Schachter J, Ilan G. Ron, Yosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, DeNardo G, DeNardo S. (2013). Safety and efficacy of 188-Rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer. 2013:828329.
163. Nechemia-Arbely Y, Khamaisi M, Rosenberger C, Koesters R, Shina A, Geva C, Shriki A, Klaus S, Rosen S, Rose- John S, Galun E, Axelrod JH, Heyman SH. (2013). In vivo evidence suggesting reciprocal renal HIF-1 up-regulation STAT3 activation in response to hypoxic and non-hypoxic stimuli. Clinical and Experimental Pharmacology and Physiology. 40:262-72.
164. Potikha T, Stoyanov E, Pappo O, Frolov A, Mizrahi L, Olam D, Shnitzer-Perlman T, Weiss I, Barashi N, Peled A, Sass G, Tiegs G, Poirier F, Rabinovich GA, Galun E, Goldenberg D. (2013). Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis. Hepatology. 58:192-204.
165. Sonnenblick A, Uziely B, Nechushtan H ,Kadouri L, Shriki A, Axelrod JH, Galun E, Katz, Daum H, Hamburger T, Mali B, Elweis TE, Peretz T. (2013). Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 138:407-13.
166. Barashi N, Weiss ID, Wald O, Wald H, Beider K, Abraham M, Klein S, Goldenberg D, Axelrod J, Pikarsky E, Abramovitch R, Zeira E, Galun E, Peled A. (2013). Inflammation induced hepatocellular carcinoma is dependent on CCR5. Hepatology 58:1021-30.
167. Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, Amariglio N, Bar-Eli M, Schachter J, Rechavi G, Markel. (2013). MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. JCI.
123:2703-18.
168. Katia B, Ribakovsky E, Abraham M, Wald H, Weiss L, Rosenberg E, Galun E, Avigdor A, Eizenberg O, Peled A, Nagler A. (2013). Targeting the CD20 and CXCR4 Pathways in Non Hodgkin Lymphoma with Rituximab and high affinity CXCR4 antagonist BKT140. Clin Cancer Res. 19:3495-507.
169. Galun E, Rose-John S. The regenerative activity of interleukin-6. (2013). Methods Mol Biol. 982:59-77.
170. Abu-Tair L, Axelrod JH, Doron S, Ovadya Y, Krizhanovsky V, Galun E, Amer J, Safadi R. (2013). Natural Killer Cell- Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9. PLoS One. 8:e82571.
171. Zorde Khvalevsky E,Gabai R,Rachmut I-H, Horwitz E, Brunschwig Z, Orbach A, Shemi A, Golan T, Domb A, Yavin E, Giladi H, Rivkin L, Simerzin A, Elyakim R, Kalila A, Hubert A, Lahav M, Kopelman Y, Goldin E, Dancour A, Hants Y, Arbel-Alon S, Abramovitch R, Shemi A, Galun E. (2013). Mutant KRAS as a druggable target for pancreatic cancer. Proc Natl Acad Sci (USA) 110:20723-8.
172. Condiotti R, Goldenberg D, Giladi H, Schnitzer-Perlman T, Waddington S, Buckley SM, Heim D, Cheung W, Themis M, Charles C, Simerzin A, Osejindu E, Wege H, Themis M, Galun E. (2014). Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature. Mol Ther. 22:59-68.
173. Peled A, Abraham M, Avivi I, Rowe JM, Beider K, Wald H, Tiomkin L, Ribakovsky L, Riback Y, Ramati Y, Aviel S, Galun E, Shaw HL, Eizenberg O, Hardan I, Shimoni A, Nagler A. (2014). The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma. Clin Cancer Res. 20:469-79.
174. Beider K, Darash-Yahana M, Blaier O, Koren-Michowitz M, Abraham M, Wald, H Wald O, Galun E, Eizenberg O, Peled A, Nagler A. (2014). Combination of Imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo. Mol Cancer Res. 13:1155-69.
175. Nachmani D, Zimmermann, Djian AEO, Manaster I, Vitenshtein A, Lee K, Galun E, Horejsi V, Isakov O, Shomron N, Wolf DG, Hengel H, Mandelboim O. (2014). MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells. PLoS Pathogens. 10(2):e1003963.
176. Beider K, Bitner H, Leiba M, Gutwein O, Koren-Michowitz M, Ostrovsky O, Abraham M, Wald H, Galun E, Peled A, Nagler N. (2014). Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype. Oncotarget 5:11283-96.
177. Ella E, Heim D, Stoyanov E, Harari-Steinfeld R, Steinfled I, Pappo O, Schnitzer Perlman T, Nachmansson N, Rivkin L, Olam D, Abramovitch R, Wege H, Galun E, Goldenberg D. (2014). Specific Genomic and Transcriptomic Aberrations i in Tumors Induced by Partial Hepatectomy of a Chronically Inflamed Murine Liver. Oncotarget 5:10318-31.
178. Rozenblum N, Zeira E, Bulvik B, Gourevitch S, Yotvat H, Galun E, Goldberg SN (2015). Radiofrequency Ablation: Inflammatory changes in the peri-ablative zone can induce global organ effects including liver regeneration. Radiology 276:416-25.
179. Rozenblum N, Zeira E, Scaiewicz V, Bulvik B, Gourevitch S, Yotvat H, Galun E, Goldberg SN (2015). Oncogenesis - an "off-target" effect of radiofrequency ablation. Radiology 276:426-32.
180. Stoyanov E, Ludwig G, Mizrahi L, Olam D, Schnitzer-Perlman T, Tasika E, Sass G, Tiegs G, Jiang Y, Nie T, Kohler J, Schinazi RF, Vertino PM, Cedar H, Galun E, Goldenberg D. (2015). Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis. Oncotarget 6(13):11047-60.
181. Golan T, Zorde Khvalevsky E, Hubert A, Malka Gabai R, Hen N, Segal A, Domb A, Harari G, Ben David E, Raskin S, Goldes Y, Goldin E, Eliakim R, Lahav M, Kopleman Y, Dancour, Shemi A, Galun E. (2015). RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Oncotarget 6:24560-70.
182. Ahmed M, Kumar G, Navarro G, Wang Y, Gourevitch S, Moussa M, Rozenblum N, Levchenko T, Galun E, Torchilin V, Goldberg SN. (2015). Systemic siRNA nanoparticle-based drugs combined with radiofrequency ablation for cancer therapy. PLoS One 10:e0128910.
183. Geiger-Maor A, Guedj A, Even-Ram S, Smith Y, Galun E, Rachmilewitz J. (2015). Macrophages regulate the systemic response to DNA damage by a cell non-autonomous mechanism. Cancer Res 75(13):2663-73.
184. Zeira E, Abramovitch R, Meir K, Even Ram S, Gil Y, Bulvik B, Bromberg Z, Levkovitch O, Nahmansson N, Adar R, Reubinoff B, Galun E, Gropp M. (2015). The knockdown of lncRNA H19 reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells. Oncotarget 6:34691-703.
185. Ahmed M, Kumar G, Moussa M, Wang Y, Rozenblum N, Galun E, Goldberg SN. (2016). Hepatic Radiofrequency ablation-induced stimulation of distant tumor growth is suppressed by c-Met inhibition. Radiology 279:103-17
186. Bulvik BE, Rosenblum N, Gourevich S, Ahmed M, Andriyanov AV, Galun E, Goldberg NS. (2016) IRE versus RFA: A comparison of local and systemic effects in a small animal model. Radiology (In press)
187. Zahavi T, Lanton T, Salmon Divon M, Salmon A, Peretz T, Galun E, Axelrod JH, Sonnenblick A. (2016). Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model. Oncotarget 7:4860-70
188. Galun E. (2016). Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor- promoting niche (TPN) in the development of hepatocellular carcinoma. Hepatology 63:354-6
189. Marmary Y, Adar R, Gaska S, Wygoda A, Maly A, Cohen J, Eliashar R, Mizrachi L, Orfaig-Geva C, Baum B, Rose- John S, Galun E, Axelrod JH. (2016). Cellular Senescence Drives Radiation-Induced Loss of Salivary Gland Function and is Prevented by IL-6 Modulation. Cancer Res 76:1170-80.
190. Potikha T, Ella E, Cerliani JP, Mizrahi L, Pappo O, Rabinovich GA, Galun E, Goldenberg D. (2016). Galectin-1 is essential for efficient liver regeneration following hepatectomy. Oncotarget 7:31738-54.
191. Kumar G, Goldberg SN, Wang Y, Velez E, Gourevitch S, Galun E, Ahmed M. (2016). Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition. Eur Radiol 27:1238-1247
192. Simerzin A, Zorde-Khvalevsky E, Rivkin M, Adar R, Zucman-Rossi J, Couchy G, Roskams T, Govaere O, Oren M, Giladi H, Galun E. (2016). The liver-specific miR-122*, the complementary strand of miR-122, acts as a tumor suppressor by modulating the p53-Mdm2 circuitry. Hepatology 64:1623-1636
193. Rivkin M, Zorde-Khvalevsky E, Simerzin A, Chai C, Yuval JB, Rosenberg N, Harari-Steinfeld R, Schneider R, Amir G, Condiotti R, Heikenwalder M, Weber A, Schramm C, Wege H, Kluwe J, Galun E*, Giladi H. (2016). Inflammation- Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-derived Erythropoietin and Anemia. Gastroenterology 151:999-1010. (* corresponding author)
194. Beider K, Rosenberg E, Bitner H, Shimoni A, Leiba M, Koren-Michowitz M, Ribakovsky L, Klein S, Olam D, Wald H, Weiss L, Abraham M, Galun E, Peled A, Nagler A. (2016) The Sphingosine 1 Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway. Clin Cancer Res. 23:1733-1747
195. Guedj A, Geiger-Maor A, Galun E, Amsalem H, Rachmilewitz J. (2016) Early Age Decline in DNA Repair Capacity in the Liver: In Depth Profile of Differential Gene Expression. Aging 8:3131-3146.
196. Lanton T, Shriki A, Nechemia-Arbely Y, Abramovitch R, Levkovitch O, Adar R, Rosenberg N, Paldor M, Goldenberg D, Sonnenblick A, Peled A, Rose-John S, Galun E, Axelrod JH. (2017). IL6-Dependent Genomic Instability Heralds Accelerated Carcinogenesis Following Liver Regeneration on a Background of Chronic Hepatitis. Hepatology 65:1600- 1611.
197. Abraham M, Klein S, Bulvik B, Wald H, Weiss I, Tavor S, Olam D, Weiss L, Beider K, Eizenberg O, Wald O, Galun E, Avigdor A, Benjamini O, Nagler A, Pereg Y, Peled A. (2017). The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by down-regulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia
(in press).
198. AvrahamY, HantsY, Vorobeiv L, Premishlano M, Wiessam AA, Mankuta D, Galun E, Arbel-Alon S. (2017). Brain neurotransmitters in an animal model with postpartum depressive – like effect behavior. Behavioural Brain Research (in press).
199. Kumar G, S. Goldberg NS, Gourevitch S, Levchenko T, Torchilin V, Galun E, Ahmed M. (2017). Targeting STAT3 to suppress systemic pro-oncogenic effects from hepatic RF ablation. Radiology (in press).
200. Stoyanov E, Mizrahi L, Olam D, Schnitzer-Perlman T, Galun E, Goldenberg D. (2017). Short-term S- adenosylmethionine supplementation suppresses tumor development in a murine model of inflammation-mediated
hepatocarcinogenesis. Oncotarget 8:104772-104784.
201. Chai C, Rivkin M, Berkovits L, Simerzin A, Zorde- Khvalevsky E, Rosenberg N, Klein S, Durst R, Shpitzen S, Udi S, Tam Y, Heeren J, Worthmann A, Schramm C, Kluwe J, Giladi H, Galun E. (2017). A Metabolic Circuit Involving Free Fatty Acids, MIR122 and Triglyceride Synthesis in the Liver and Muscle Tissues. Gastroenterology 153:1404-1415.
Response letter to the editor: Chai C, Galun E, Giladi H. Gastroenterology. 2018 Apr;154(5):1553-1554.
202. Abraham M, Pereg Y, Bulvik B, Klein S, Mishalian I, Wald H, Eizenberg O, Beider K, Nagler A, Golan R, Vainstein A, Aharon A, Galun E, Caraco Y, Or R, Peled A. (2017). Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers. Clin Cancer Res. 23:6790-6801.
203. Abraham M, Wald H, Vaizel-Ohayon D, Grabovsky V, Oren Z, Karni A, Weiss L, Galun E, Peled A, Eizenberg O. (2017). Development of novel promiscuous anti-chemokine peptibodies for treating autoimmunity and inflammation. Frontiers in Immunology 8:1432.
204. Kleinschmidt D, Giannou DA, McGee HM, Kempski J, Steglich B, Huber FJ, Ernst MT, AM Shiri, Wegscheid C, Tasika E, Hübener P, Huber P, Bedke T, Steffens N, Agalioti T, Fuchs T, Noll J, Lotter H, Tiegs G, Lohse AW, Axelrod JH,
Galun E, Flavell RA, Gagliani N, Huber S. (2017). A protective function of IL-22BP in ischemia reperfusion and acetaminophen induced liver injury. JI 199:4078-4090.
205. Moll JM, Wehmöller M, Frank NC, Homey L, Baran P, Garbers C, Lamertz L, Axelrod JH, Galun E, Mootz HD,
Scheller J. (2017). Split2 protein-ligation generates active IL-6-type Hyper-cytokines from inactive precursors. ACS Synth Biol. 6:2260-2272.
206. Ahmed M, Kumar G, Gourevitch S, Levchenko T, Galun E, Torchilin V, Goldberg SN. (2018). Radiofrequency ablation (RFA) induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins.
Int J Hyperthermia 9:1-25.
207. Werlin S, Scotet V, Audrezet MP, Uguen K, Cohen M, Yaakov Y, Safadi R, Ilan Y, Konikoff F, Galun E, Mizrachi M,
Slae M, Sayag S, Cohen-Cymberknoh M, Wilschanski M, Ferec C. (2018). Primary Sclerosing Cholangitis is associated with abnormalities in CFTR. Journal of Cystic Fibrosis 17:666-671.
208. Kumar G, S. Goldberg NS, Gourevitch S, Levchenko T, Torchilin V, Galun E, Ahmed M. (2018). Targeting STAT3 to suppress systemic pro-oncogenic effects from hepatic RF ablation. Radiology 286:524-536.
209. Potikha T, Pappo O, Mizrahi L, Olam D, Maller SM, Rabinovich GA, Galun E, Goldenberg DS. (2019). Lack of galectin- 1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
FASEB J. 33:7995-8007.
210. Gozlan Y, Bucris E, Shirazi R, Rakovsky A, Ben-Ari Z, Davidov Y, Veizman E, Saadi T, Braun M, Cohen-Naftaly M, Shlomai A, Shibolet O, Zigmond E, Katchman H, Menachem Y, Safadi R, Galun E, Zuckerman E, Nimer A, Hazzan R, Maor Y, Saif AM, Etzion O, Lurie Y, Mendelson E, Mor O. (2019). High frequency of multiclass HCV resistance- associated mutations in patients failing direct-acting antivirals: real-life data. Antivir Ther. 24:221-228.
211. Benedek G, Abed El-Latif M, Miller K, Galun E, Levite M. (2019). Identification of the novel HLA-B allele, HLAB*15:539, in a South-Sudanese individual. HLA 94:380-381.
212. Liao H, Ahmed M, MD, Markezana A, Zeng G, Stechele M, Galun E, Goldberg, NS. (2020). Thermal ablation induces time-dependent transitory intrahepatic metastatic growth via the STAT3/c-Met molecular pathway.
Radiology 294:464-472.
213. Birger A, Ben-Dor I, Ottolenghi M, Turetsky T, Gil Y, Sweetat S, Perez L, Belzer V, Casden N, Steiner D, Izrael M,
Galun E, Feldman E, Behar O, Reubinoff B. (2019). Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50:274-289.
214. Guedj A, Volman Y, Geiger-Maor A, Bolik J, Schumacher N, Künzel S, Baines JF, Nevo Y, Elgavish S, Galun E, Amsalem H, Schmidt-Arras D, Rachmilewitz J. (2020). Gut microbiota shape “inflamm-aging” cytokines and account for age-dependent decline in DNA damage repair. Gut 69:1064-1075.
215. Markezana A, Ahmed M, Kumar G, Zorde-Khvalevsky E, Rozenblum N, Galun E, Goldberg SN. (2021) Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity. Int J Hyperthermia. 37:119-129.
216. Levite M, Zelig D, Friedman A, Ilouz N, Eilam R, Bromberg Z, Ramadhan Lasu AA, Arbel-Alon S, Edvardson S, Tarshish M, Riek LP, Lako RL, Reubinoff B, Lebendiker M, Yaish D, Stavsky A, Galun E. (2020). Dual-targeted Autoimmune Sword in Fatal Epilepsy: Patient’s glutamate receptor AMPA GluR3 autoimmune antibodies bind, induce ROS, and kill both human neural cells and T cells. J of Autoimmunity (in press).
217. Chai C, Cox B, Yaish D, Gross D, Rosenberg N, Amblard F, Shemuelian Z, Gefen M, Korach A, Tirosh O, Lanton T,
Link H, Tam J, Permikov A, Ozhan G, Citrin J, Liao H, Tannous M, Hahn M, Axelrod J, Arretxe E, Alonso E, Martinez- Arranz I, Ortiz Betés P, Safadi R, Salhab A, Amer J, Tber Z, Mengshetti S, Giladi H, Schinazi RF, Galun E. (2020). Agonist of RORA Reduces Progression of Fatty Liver in Mice via Upregulation of microRNA 122.
Gastroenterology 159:999-1014. Response letter to the editor: Chai C, Giladi H, Galun E. (2021).
Gastroenterology 160:1882-1883.
218. Benedek G, El Latif MA, Miller K, Rivkin M, Lasu AAR, Riek LP , Lako R, Edvardson S, Arbel-Alon S, Galun E,
Levite M. (2020). Protection or susceptibility to devastating childhood epilepsy: Nodding Syndrome associates with immunogenetic fingerprints in the HLA binding groove. PLOS Neglected Tropical Diseases 14:e0008436.
219. Gamaev L, Mizrahi L, Friehmann T, Rosenberg N, Pappo O, Olam D, Zeira E, Halpern KB, Caruso S, Zucman-Rossi J, Axelrod JH, Galun E, Goldenberg DS. 2021. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma. Oncogene 40:127-139.
220. Sadeh R , Sharkia I , Fialkoff G , Rahat A , Gutin J, Chappelboim A, Nitzan M , Ilana Fox-Fisher I , Neiman D, Meler G, Kamari Z , Yaish D , Peretz T , Hubert A, Cohen JE , Azzam S, Mark Temper M, Grinshpun A , Maoz M , Abu-Gazala S, Ben Yaacov A , Shteyer E, Safadi R, Kaplan T , Shemer R, Planer D , Galun E , Glaser B, Zick A, Dor Y , Friedman N. 2021. ChIP-seq of plasma cell-free nucleosomes identifies cell-of-origin gene expression programs. Nature Biotechnology 39:586-598.
221. Harari-Steinfeld R, Gefen M, Simerzin A, Zorde-Khvalevski E, Rivkin M, Ella E, Friehmann T, Gerlic M,
Zucman Rossi J, Caruso S, Leveille M, Estall J, Goldenberg DS, Giladi H, Galun E*, Bromberg Z. 2021. The lncRNA H19-derived microRNA-675 Promotes Liver Necroptosis by Targeting FADD. Cancers (in press).
222. Schmidt-Arras D, Galun E, Rose-John S. (2021). The two facets of gp130 signalling in liver tumorigenesis. Seminars in Immunopathology (in press).
223. Levite M, Safadi R, Milgrom Y, Massarwa M, Galun E. (2021). Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells. Neuropeptides (in press).
224. Shriki A, Lanton T, Sonnenblick A, Levkovitch-Siany O, Eidelshtein D, Abramovitch R, Rosenberg N, Pappo O, Elgavish S, Nevo Y, Safadi R, Peled A, Rose-John S, Galun E*, Axelrod JH. (2021). Decisive Roles of IL-6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis. Cancer Res (in press).
225. Benedek G, El Latif MA, Miller K, Rivkin M, Ramadhan AAL, Riek LP, Lako R, Edvardson S, Arbel Alon S, Galun E, Levite M. (2021). Macrophage migration inhibitory factor in Nodding Syndrome. PLoS Neglected Tropical Diseases (in press).